1.
Niktoreh N, Lerius B, Zimmermann M, Gruhn B, Escherich G, Bourquin J-P, Dworzak M, Sramkova L, Rossig C, Creutzig U, Reinhardt D, Rasche M. Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group. Haematologica 2018; 104(1):120-127; https://doi.org/10.3324/haematol.2018.191841.